900 MIDDLESEX TURNPIKE, BILLERICA, MA
News, Articles of Incorporation, Bylaws
News
Annual Report to Security Holders
Releases Financial Results for the Second Quarter of 2025
Announces Cooperation Agreement with Kent Lake Capital
Costs of Shutting Down or Selling Parts of the Business
Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum
Q2
Q1
FY 2024
Q3
Amended Quarterly Report
Amended Annual Report
Notice of Late Filing for Quarterly Report
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Prospectus Filed Pursuant to Rule 425
S-4/A
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Definitive Additional Information Statement
Statement of Changes in Beneficial Ownership
S-8 POS
Post-Effective Amendment to Registration Statement
Specialized Disclosure Report